Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu
- 15 January 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (2), 703-705
- https://doi.org/10.1182/blood-2002-06-1874
Abstract
P38 mitogen-activated protein kinase (MAPK) is a member of the MAPK family which is activated by cytokines and growth factors, but its role in pathogenesis of multiple myeloma (MM) is unknown. In this study, we demonstrate that the specific p38 MAPK inhibitor VX-745 inhibits interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) secretion in bone marrow stromal cells (BMSCs), without affecting their viability. Tumor necrosis factor alpha (TNF-α)–induced IL-6 secretion in BMSCs is also inhibited by VX-745. Importantly, VX-745 inhibits both MM cell proliferation and IL-6 secretion in BMSCs triggered by adherence of MM cells to BMSCs, suggesting that it can inhibit paracrine MM cell growth in the BM milieu and overcome cell adhesion–related drug resistance. These studies therefore identify p38 MAPK as a novel therapeutic target to overcome drug resistance and improve patient outcome in MM.Keywords
This publication has 19 references indexed in Scilit:
- Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaBlood, 2002
- NF-κB as a Therapeutic Target in Multiple MyelomaJournal of Biological Chemistry, 2002
- Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsLeukemia, 2001
- Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myelomaOncogene, 2001
- The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma: therapeutic applicationsOncogene, 2001
- Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migrationBlood, 2001
- p38 MAPK and NF-κB Collaborate to Induce Interleukin-6 Gene Expression and ReleaseJournal of Biological Chemistry, 2000
- Tumor Necrosis Factor-α Induces Interleukin-6 Production and Integrin Ligand Expression by Distinct Transduction PathwaysJournal of Biological Chemistry, 1998
- Tumor Necrosis Factor ä-Induced E-selectin Expression Is Activated by the Nuclear Factor-κB and c-JUN N-terminal Kinase/p38 Mitogen-activated Protein Kinase PathwaysJournal of Biological Chemistry, 1997
- Interleukin-6 Inhibits Apoptosis of Malignant Plasma CellsCellular Immunology, 1995